key: cord-0007418-9z0lo2d1 authors: Feng, Youjun; Zheng, Feng; Pan, Xiuzhen; Sun, Wen; Wang, Changjun; Dong, Yaqing; Ju, Ai-ping; Ge, Junchao; Liu, Di; Liu, Cuihua; Yan, Jinghua; Tang, Jiaqi; Gao, George F. title: Existence and characterization of allelic variants of Sao, a newly identified surface protein from Streptococcus suis date: 2007-10-01 journal: FEMS Microbiol Lett DOI: 10.1111/j.1574-6968.2007.00859.x sha: 4a6a830e2a187d55f7cfb44b078b3a8b65081c1c doc_id: 7418 cord_uid: 9z0lo2d1 Surface antigen one (Sao) is a newly identified protein from the major zoonotic pathogen, Streptococcus suis. In search of functional proteins related to the pathogenesis of Chinese S. suis 2 (SS2), unexpectedly, a variant of Sao protein was obtained. To test its prevalence in S. suis, PCR assay was adopted to address the coding genes systematically. It was found that there are three allelic variants of sao gene, namely sao-S, sao-M, and sao-L based on the different lengths of the genes (∼1.5, ∼1.7, and ∼2.0 kb, respectively). These differences were determined to be caused by heterogeneity within the number of C-terminal repeat sequences (R), which had been seen as a pathogenicity-related domain in the plant pathogen, Xanthomonas oryzae. Two variants (sao-M and sao-L) were only found in SS2. All three variant proteins were prepared in vitro and their biochemical and biophysical properties were characterized. A soluble form of Sao-M protein was then used as a capture antigen to develop an enzyme-linked immunosorbent assay method to detect antibodies against SS2 in convalescent pig sera. Taken together, the results exhibit the properties of Sao proteins and provide an efficient Sao-M-based method for monitoring SS2 infection. Streptococcus suis infection of swine is recognized as the leading cause of highly invasive diseases such as meningitis, septicemia, arthritis, and even sudden death, and has spread over 20 countries, resulting in great economic losses in pigindustries each year (Staats et al., 1997; Huang et al., 2005) . Streptococcus suis is also a notorious zoonotic agent responsible for more than 200 cases of severe infections in humans worldwide since its first discovery in Denmark in 1968 (Staats et al., 1997) . Thirty-five serotypes of S. suis have been determined based on differences among their capsule antigens (Staats et al., 1997) . However, Hill et al. (2005) recently suggested that the two serotypes (serotype 32 and serotype 34) may be excluded from S. suis species and redesignated as Streptococcus orisratti. Virulence varies greatly among the serotypes and can be divided into three groups: highly pathogenic, hypovirulent, and avirulent (Staats et al., 1997) . Streptococcus suis 2 (SS2) is the most prevalent serotype isolated from both diseased piglets and patients worldwide and is often associated with severe clinical syndrome (Staats et al., 1997) . In particular, two large-scale outbreaks of lethal SS2 infections with a hallmark of streptococcal toxic shock syndrome (STSS) emerged in China (one in Jiangsu Province, 1998, and the other in Sichuan Province, 2005) , posing a great global concern to the public health (Tang et al., 2006) . As it is known that human SS2 infections have been documented for several decades, the molecular mechanism underlying the high pathogenicity of this bacterial agent is still poorly understood (Staats et al., 1997; Gottschalk et al., 1999) . Several bacterial components have been previously implicated in S. suis virulence, but the exact role remains unclear (Staats et al., 1997; Gottschalk et al., 1999; Gottschalk & Segura, 2000) . So far, the virulence-associated factors identified include components of capsule polysaccharide (CPS) (Smith et al., 2000) , extracellular factor (EF) (Smith et al., 1993; Staats et al., 1999) , muraminidase-released protein (MRP) (Staats et al., 1999) , suilysin (Allen et al., 2001; Lun et al., 2003) , adhesions (Tikkanen et al., 1996; Brassard et al., 2004) , 38 kDa protein (Okwumabua & Chinnapapakkagari, 2005) , glutamate dehydrogenase (GDH) (Okwumabua et al., 2001) , fibronectin-binding protein (FBP) (de Greeff et al., 2002; Wang, 2006) , hayluronate lyase (King et al., 2004) , sortase A (srtA) (Osaki et al., 2002) , arginine deiminase (Gruening et al., 2006) , etc. In some instances, the virulence determination of some S. suis strains was still ambiguous, indicating that the virulence of S. suis is a complex interplay between the pathogen, its host, and the environment (Gottschalk et al., 1999) . Considerable efforts to control severe SS2 infections have still been hampered greatly by the limited knowledge of S. suis pathogenesis (Staats et al., 1997; Gottschalk et al., 1999; Gottschalk & Segura, 2000; Haesebrouck et al., 2004) . It is widely accepted that the cell-wall-exposed proteins/ outer surfaces of pathogenic bacteria are of great importance to understanding their pathogenesis (Navarre & Schneewind, 1999; Cabanes et al., 2002) . Not only are surface-associated components implicated in bacterial defense machineries but also they are involved in virulencerelated behaviors (e.g., adhesion) (Navarre & Schneewind, 1999; Maione et al., 2005) . Thus, for vaccine development against pathogenic bacteria, current interest has shifted from the CPS antigen to surface proteins with robust immunogenicity (Navarre & Schneewind, 1999; Cabanes et al., 2002; Maione et al., 2005; Li et al., 2006) . Whole genome-wide screening was carried out to search for a universal Group B Streptococcus (GBS) vaccine (Maione et al., 2005) . These surface proteins containing a C-terminal cell wall anchoring motif (LPXTG) have been found in a variety of pathogenic microorganisms, and suggested to execute key steps during the process of infection, which range from colonization to invasion (Navarre & Schneewind, 1999; Cabanes et al., 2002; Osaki et al., 2002; Maione et al., 2005) . In S. suis, MRP belongs to this type of surface protein (Smith et al., 1992) . More recently, Li et al. (2006) reported a novel surface protein, surface antigen one (Sao), from S735 strain of SS2, and evaluated its potential as a vaccine . Although it failed to protect piglets against SS2 infection completely, it was not determined whether or not this protein played any role in S. suis infection. The availability of the whole genomes of SS2 Chinese strains allows to mine the functional proteins related to high virulence (Chen et al., 2007) . During a genome-wide in silico screening for surface-exposed proteins or cell wall-associated proteins, a mutant of sao was accidentally found, in which 270 bp of repeated sequences at the 3 0 -terminus was deleted. In light of this unexpected observation, it was attempted to examine the prevalence in various serotypes of S. suis, and test its possible genetic variation or molecular polymorphism. Thus, PCR screening was undertaken to test more than 50 different S. suis strains comprising 34 kinds of serotypes (except for S. suis 12). It was found that Sao proteins exhibit obvious polymorphisms with considerable genetic variation. Furthermore, it was possible to classify Sao into three groups and the proteins were also characterized via a range of biochemical techniques. Immunological data from Western blotting and enzyme-linked immunosorbent assay (ELISA) also demonstrated that Sao-M, the most common type of Sao, has strong immunogenicity. Sao-M has been successfully developed into an effective ELISA method for monitoring S. suis infection in both pigs and humans. Therefore, Sao may serve as a useful marker for clinical surveillance of S. suis infection. Strains, plasmids, and culture conditions The reference strains of S. suis (34 kinds of serotypes) were kindly provided by Prof. Marcelo Gottschalk in Canada and Prof. Astrid de Greeff in Holland. The other SS2 isolates were all kept in the authors' laboratory (listed in Table S1 ). Streptococcus suis were cultivated in Todd-Hewitt Broth (THB, code CM189; Oxoid) at 37 1C for preparing chromosomal DNA as a PCR template (Tang et al., 2006) . Escherichia coli strains DH5a and BL21 (DE3) were maintained in Luria-Bertani (LB) broth or agar medium at 37 1C for recombinant plasmid amplification and protein expression, respectively (Liu et al., 2006) . The commercial pMD18-T vector (Takara) and pET28a (Novagen) were utilized to clone PCR fragments for direct sequencing of sao genes, and construct recombinant expression plasmids, respectively. Streptococcus suis genomic DNAs were extracted using the routine CTAB method as described by Tang et al. (2006) , and their size and quality were evaluated by electrophoresis on a 0.8% agarose gel (Brazil) before they were used as templates of PCR amplification for sao. If necessary, two sets of primers specific for S. suis house-keeping genes, 16S rRNA gene and gyrase, were utilized to further assess the quality of DNA templates. To amplify sao genes, the specific primers (S-F: 5 0 -ATGAATACTAAGAAATGGAG-3 0 ; S-R: 5 0 -TTATAATTTAC GTTTACGTGT-3 0 ) were designed, which, according to the available sequence information, cover the entire putative ORF. Subsequently, the standard PCR in a total volume of 50 mL was conducted in a PTC-225 thermocycler (MJ Research) using ExTaq (Takara). All the candidate PCR products were ligated into a pMD18-T vector (Takara) as the recommended protocol to obtain unique clones for direct DNA sequencing by an ABI 3730 DNA sequencer (Perkin-Elmer Applied Biosystems). To prepare the soluble recombinant Sao proteins, it was attempted to construct three plasmids using PCR products generated with the primers (Sao-F: 5 0 -CG GGATCC CAAG AAGTAAAAAATACCATC-3 0 ; Sao-R: 5 0 -CCAA GTCGAC TTATTTCTCACCAGTTACTGG-3 0 ). The primers introduced BamHI and SalI sites into the truncated DNA fragments. The truncated DNA fragments from three sao variants (88-1938 bp of sao-L, 88-1668 bp of sao-M, and 88-1395 bp of sao-S) equivalent to mature extra-domains (30-646 aa of Sao-L, 30-556 aa of Sao-M, and 30-465 aa of Sao-S) were introduced into the BamHI and XhoI sites of pET28a (Novagen). Finally, the resulting recombinant plasmids, designated pET28